Doxylamine hydrogen succinate
The active substance in Doxylamine Biofarm is doxylamine, which belongs to the group of antihistamine medicines. These medicines are characterized by a sedative effect, which means they are effective as aids to sleep.
Doxylamine Biofarm is indicated for short-term, symptomatic treatment of occasional insomnia in adults, especially when there are difficulties falling asleep, frequent nocturnal awakenings, or early morning awakenings.
Before taking Doxylamine Biofarm, discuss with your doctor or pharmacist:
Effect on diagnostic tests
Doxylamine Biofarm may alter the results of skin allergy tests. If you are referred for such tests, you should stop taking Doxylamine Biofarm 3 days before the tests and inform your doctor.
Doxylamine Biofarm is not recommended for use in children and adolescents under 18 years of age - see also "Use in children and adolescents".
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
Do not take Doxylamine Biofarm while taking the following medicines:
Patients should avoid taking Doxylamine Biofarm while taking the following medicines, as it may increase their effect or cause side effects:
There are no special recommendations for taking this medicine with or without food.
It is not recommended to drink grapefruit juice while taking Doxylamine Biofarm.
Do not drink alcohol while taking Doxylamine Biofarm.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
There is not enough data on the use of doxylamine in pregnant women, so the use of Doxylamine Biofarm in pregnant women is contraindicated.
Due to the risk associated with the use of antihistamines in small children, Doxylamine Biofarm should not be used in breastfeeding women.
There is no available data on the effect of Doxylamine Biofarm on fertility.
Doxylamine Biofarm may cause drowsiness the next day after taking it, which may affect your ability to drive and use machines. Therefore, during the treatment period, you should avoid driving and using machines, at least for the first few days of treatment, until you determine how Doxylamine Biofarm affects your ability to drive vehicles and operate machinery.
If you have been told that you have an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
This medicine should always be taken exactly as directed by your doctor. If you are unsure, ask your doctor or pharmacist.
Adults (over 18 years old)
The recommended dose is 12.5 mg (half a tablet) taken 30 minutes before bedtime.
The dose may be increased to a maximum of 25 mg (one tablet) taken 30 minutes before bedtime if the initial dose does not provide sufficient relief from insomnia symptoms.
The maximum daily dose is 25 mg (one tablet).
If you experience daytime sleepiness, it is recommended to reduce the dose to 12.5 mg (half a tablet) or ensure at least an 8-hour interval between taking the medicine and planned wake-up time.
Elderly (over 65 years old)
In adults over 65 years old, it is more likely that other conditions may require dose reduction. The recommended initial dose is 12.5 mg (half a tablet), given 30 minutes before bedtime. The dose can be increased to 25 mg (one tablet) if the initial dose is ineffective. If side effects occur, the dose should be reduced to 12.5 mg (half a tablet) per day. Therefore, attention should be paid to the effects of treatment (see section 4). If side effects occur, consult your doctor.
Patient with kidney or liver impairment
Doxylamine Biofarm is contraindicated in patients with severe kidney or liver disease, as well as in patients with end-stage renal failure.
Doxylamine Biofarm should not be used in patients with moderate kidney or liver disease.
In patients with mild kidney or liver disease, it is recommended to reduce the maximum daily dose to 12.5 mg (half a tablet).
Doxylamine Biofarm is not indicated for use in children and adolescents under 18 years of age and should not be used in this patient group.
Route and method of administration
Oral use.
Tablets should be taken 30 minutes before bedtime, with an appropriate amount of liquid (preferably water).
Doxylamine Biofarm can be taken with or without food.
The 25 mg (one tablet) Doxylamine Biofarm tablet can be divided into two equal doses.
Treatment should be as short as possible. Treatment usually lasts from a few days to one week. Treatment should be stopped after a maximum of two weeks of daily use.
If you have taken more than the recommended dose, contact your doctor immediately.
Your doctor will decide what measures should be taken.
Symptoms of overdose are: drowsiness, central nervous system depression or stimulation, anticholinergic effects (dilated pupils, fever, dry mouth, decreased smooth muscle tone in the intestines), increased or changed heart rate, increased blood pressure, nausea, vomiting, stimulation, disorientation, and hallucinations.
Severe poisonings can cause delirium, psychotic disorders, decreased blood pressure, seizures, decreased respiratory rate, loss of consciousness, coma, and can be life-threatening. A serious complication is rhabdomyolysis (muscle breakdown), followed by kidney failure.
There is no specific antidote in case of overdose of antihistamines. If necessary, symptomatic and supportive treatment should be applied. The doctor will decide whether to induce vomiting, perform gastric lavage, or prescribe medicines to increase blood pressure.
Do not take a double dose to make up for a forgotten dose.
Take the next dose at the usual time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Doxylamine Biofarm can cause side effects, although not everybody gets them.
Doxylamine Biofarm may cause a significant decrease in the number of white blood cells in the blood and lower resistance to infections.
If you experience an infection with symptoms of fever and a serious deterioration in general condition or fever with local symptoms of infection, such as sore throat or urinary tract pain, contact your doctor immediately.
A blood test will be performed to check for a possible decrease in the number of white blood cells (agranulocytosis). It is important to inform your doctor that you are taking Doxylamine Biofarm.
Side effects are ranked according to frequency:
Very common(more than 1 in 10):
Common(between 1 in 10 and 1 in 100):
Uncommon(between 1 in 100 and 1 in 1,000):
Rare(between 1 in 1,000 and 1 in 10,000):
Frequency not known(frequency cannot be estimated from the available data):
Other side effects usually caused by antihistamines, which do not have specific relevance to doxylamine, include: heart rhythm disorders (changes in heart rate), palpitations, bile reflux, liver function disorders (cholestatic jaundice), QT interval prolongation in the ECG (heart disease), loss of appetite, increased appetite, muscle pain, coordination disorders, extrapyramidal disorders (movement disorders), depression, decreased mucus production in the bronchi, hair loss, allergic skin inflammation, excessive sweating, hypersensitivity to light, or hypotension (low blood pressure).
The severity and frequency of side effects can be controlled by reducing the daily dose.
Adults over 65 years old are more prone to side effects, as they may have other conditions or be taking other medicines. These individuals are also more prone to falls.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C
02-222 Warsaw
phone: +48 22 49 21 301
fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 30°C.
Do not use this medicine after the expiry date stated on the carton and blister.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Doxylamine Biofarm, 25 mg:
oval, coated tablets, white, convex on both sides with a transverse score line on one side, allowing the tablet to be divided into two equal doses.
PVC/PVDC/Aluminum blister pack in a cardboard box.
Pack sizes:
Doxylamine Biofarm, 25 mg: 10, 14, 20, 28, or 30 coated tablets
Biofarm Sp. z o.o.
Wałbrzyska Street 13
60-198 Poznań
phone: +48 61 66 51 500
fax: +48 61 66 51 505
email: biofarm@biofarm.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.